Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Johnson & Johnson To Pay $2.2 Billion To End U.S. Marketing Probes-Reuters


Monday, 4 Nov 2013 10:30am EST 

Reuters reported that Johnson & Johnson will pay $2.2 billion to the U.S. government to end multiple investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses. The settlement with the Company and its subsidiaries covers the marketing of schizophrenia treatment Risperdal and of heart drug Natrecor. 

Company Quote

25.83
 --
24 Dec 2014